The Journal of clinical psychiatry

publication venue for

Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression. 2018
Body dysmorphic disorder: diagnosis and treatment of imagined ugliness. 1996
Psychopharmacological screening criteria. APA Committee on Research on Psychiatric Treatments. 1992
ECT as a treatment alternative for patients with symptoms of neuroleptic malignant syndrome. 1987
Imipramine-induced tremor: effects of a beta-adrenergic blocking agent. 1983
Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: Mismatch of Evidence and Insurance Coverage Policies in the United States.. 84. 2023
Prevalence and Correlates of Prescription Stimulant Misuse Among US College Students: Results From a National Survey.. 84. 2022
Faces Scales for Anxiety and Anger: A National Study of Measurement Properties.. 83. 2022
Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Treatment-Resistant Depression: A Decade of Clinical Follow-Up.. 82. 2021
Inaccurate Prescribing Warnings in Electronic Medical Record Systems: Results From an American Society of Clinical Psychopharmacology Membership Survey.. 80. 2018
Twelve-Month Outcomes Following Successful Panic-Focused Psychodynamic Psychotherapy, Cognitive-Behavioral Therapy, or Applied Relaxation Training for Panic Disorder.. 79. 2018
Effects of a Course of Right Unilateral Ultrabrief Pulse Electroconvulsive Therapy Combined With Venlafaxine on Insomnia Symptoms in Elderly Depressed Patients.. 79. 2018
Side Effects to Antidepressant Treatment in Patients With Depression and Comorbid Panic Disorder.. 78. 2017
The Association of Baseline Suicidality With Treatment Outcome in Psychotic Depression.. 78. 2017
Association Between Stigma and Depression Outcomes Among Chinese Immigrants in a Primary Care Setting.. 77. 2016
The Effectiveness of Telepsychiatry-Based Culturally Sensitive Collaborative Treatment for Depressed Chinese American Immigrants: A Randomized Controlled Trial.. 77. 2016
Psychotherapies for Panic Disorder: A Tale of Two Sites.. 77. 2016
Baseline disability and poor functioning in bipolar disorder predict worse outcomes: results from the Bipolar CHOICE study.. 77. 2016
Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): a pragmatic 6-month trial of lithium versus quetiapine for bipolar disorder.. 77. 2016
Recommendations for the monitoring of serum concentrations of antipsychotic drugs in the treatment of schizophrenia.. 76. 2015
Positive psychiatry: its time has come.. 76. 2015
Impaired insight into delusions predicts treatment outcome during a randomized controlled trial for Psychotic Depression (STOP-PD study).. 76. 2015
A gender analysis of the study of pharmacotherapy of psychotic depression (STOP-PD): gender and age as predictors of response and treatment-associated changes in body mass index and metabolic measures.. 74. 2013
The computerized adaptive diagnostic test for major depressive disorder (CAD-MDD): a screening tool for depression.. 74. 2013
A controlled clinical treatment trial of interpersonal psychotherapy for depressed pregnant women at 3 New York City sites.. 74. 2013
Caring for returning Veterans: meeting mental health needs.. 74. 2013
Phenotypic differences between pregnancy-onset and postpartum-onset major depressive disorder.. 73. 2012
The impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on prescribing practices: an analysis of data from a large midwestern state.. 73. 2011
Association between patient beliefs regarding assigned treatment and clinical response: reanalysis of data from the Hypericum Depression Trial Study Group.. 72. 2011
Effectiveness and safety of vagus nerve stimulation for severe treatment-resistant major depression in clinical practice after FDA approval: outcomes at 1 year.. 72. 2011
Time to treatment response in first-episode schizophrenia: should acute treatment trials last several months?. 72. 2011
Geriatric psychopharmacology: evolution of a discipline.. 71. 2010
Antidepressant use in elderly suicide victims in New York city: an analysis of 255 cases.. 70. 2009
Patient preference as a moderator of outcome for chronic forms of major depressive disorder treated with nefazodone, cognitive behavioral analysis system of psychotherapy, or their combination.. 70. 2009
Missed diagnosis of psychotic depression at 4 academic medical centers.. 69. 2008
Virtual reality exposure therapy for the treatment of posttraumatic stress disorder following September 11, 2001.. 68. 2007
Antidepressants in adult suicides in New York City: 2001-2004.. 68. 2007
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.. 68. 2007
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study.. 68. 2007
Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study.. 68. 2007
Persisting low use of antipsychotics in the treatment of major depressive disorder with psychotic features.. 68. 2007
Pilot randomized controlled trial of interpersonal counseling for subsyndromal depression following miscarriage.. 67. 2006
Suicidal ideation and suicide attempts in body dysmorphic disorder.. 66. 2005
Substance use disorders in individuals with body dysmorphic disorder.. 66. 2005
Modafinil treatment for fatigue in HIV+ patients: a pilot study.. 65. 2004
Alcohol use disorder comorbidity in eating disorders: a multicenter study.. 65. 2004
Paroxetine, other antidepressants, and youth suicide in New York City: 1993 through 1998.. 65. 2004
Childhood maltreatment as a risk factor for adult cardiovascular disease and depression.. 65. 2004
Pharmacologic treatments of major depression: are two mechanisms really better than one?. 65 Suppl 4. 2004
The relationship of chronic pain and depression.. 65 Suppl 12. 2004
An open-label study of citalopram in body dysmorphic disorder.. 64. 2003
Venlafaxine in treatment-resistant obsessive-compulsive disorder.. 64. 2003
Introduction: treating depression and anxiety to remission.. 64 Suppl 15. 2003
Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression.. 63. 2002
Effectiveness of pharmacotherapy for body dysmorphic disorder: a chart-review study.. 62. 2001
Delusionality and response to open-label fluvoxamine in body dysmorphic disorder.. 62. 2001
A history of substance abuse complicates remission from acute mania in bipolar disorder.. 60. 1999
Antidepressant treatment of depression in HIV-seropositive women.. 60. 1999
Open trial of flutamide for treatment of obsessive-compulsive disorder.. 60. 1999
Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine.. 59. 1998
A comparison study of body dysmorphic disorder and obsessive-compulsive disorder.. 59. 1998
The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies.. 59. 1998
The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine.. 59. 1998
The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine.. 59. 1998
A post hoc comparison of paroxetine and nortriptyline for symptoms of traumatic grief.. 59. 1998
Efficacy and safety of fluvoxamine in body dysmorphic disorder.. 59. 1998
Rapid titration of mood stabilizers predicts remission from mixed or pure mania in bipolar patients.. 59. 1998
Introduction. Reboxetine: a new selective antidepressant for the treatment of depression.. 59 Suppl 14. 1998
The dynamics of sex: gender differences in psychiatric disorders.. 58 Suppl 15. 1997
Memory functioning in Lyme borreliosis.. 57. 1996
Trichotillomania and self-esteem: a survey of 62 female hair pullers.. 57. 1996
Medication use during psychoanalysis: a survey.. 56. 1995
Body dysmorphic disorder: does it have a psychotic subtype?. 54. 1993
Serotonergic medications for sexual obsessions, sexual addictions, and paraphilias.. 53. 1992
Experiences with depression in a dementia clinic.. 52. 1991
Long-term follow-up of chronic depression treated with imipramine.. 52. 1991
Elevated blood neutrophil concentration in mania.. 47. 1986
Discussion of "controversies in psychiatry": depression in the medically ill, sleep disorders in the elderly, and the DST.. 46. 1985
Late-onset delusional depression: a distinct clinical entity?. 45. 1984
Diagnosis and treatment of depression in the cancer patient.. 45. 1984
Affective and character pathology of suicidal adolescent and young adult inpatients.. 45. 1984
Controversies in antidepressant therapy.. 44. 1983
Mania scale scores, signs, and symptoms in forty inpatients.. 44. 1983
Central noradrenergic neurons: identification, distribution and synaptic interactions with axons containing morphine-like peptides.. 43. 1982
Clonidine: basic and clinical perspectives.. 43. 1982
Catecholamine measures for diagnosis and treatment of patients with depressive disorders.. 41. 1980
A star-struck service: impact of the admission of a celebrity to an inpatient unit.. 39. 1978
Studies with oral lorazepam in anxiety neurosis associated with depressive symptomatology.. 39. 1978
Pharmacotherapy for late-life depression.. 72. 2011
Antidepressant augmentation: good news, limitations, and stumbling blocks. 2015
Questions raised by the failure of a trial of short-term psychodynamic therapy versus pharmacotherapy for major depressive disorder. 2012
Dr McClintock and Colleagues Reply. 2018
Dr McClintock and Colleagues Reply. 2018
Effects of Rapastinel (Formerly GLYX-13) on Serum Brain-Derived Neurotrophic Factor in Obsessive-Compulsive Disorder. 2018
Brief pulse and ultrabrief pulse right unilateral electroconvulsive therapy (ECT) for major depression: efficacy, effectiveness, and cognitive effects. 2014
Dr Gibbons and colleagues reply. 2014
Does depressive state influence reported attachment status? 2009
Chronic leukocytosis associated with clozapine: a case series. 2007
Agitated depression, panic anxiety, and clonazepam. 2006
Fatal body dysmorphic disorder by proxy. 2001
Low-dose lithium augmentation of divalproex in geriatric mania. 2000
Muscle dysmorphia. 1997
Methylphenidate and SSRI-Induced sexual side effects. 1996
Pimozide in clinical psychiatry. 1991
Carbamazepine treatment for stuttering. 1988
Agoraphobia and paroxysmal cerebral dysrhythmia. 1987
The history and current state of antidepressant clinical trial design: a call to action for proof-of-concept studies. 2008
The state of knowledge of chronic depression. 2006
Using antipsychotic agents in older patients. 2004
Neuropsychological Test Performance to Enhance Identification of Subjects at Clinical High Risk for Psychosis and to Be Most Promising for Predictive Algorithms for Conversion to Psychosis: A Meta-Analysis. 2017
An overview of vortioxetine. 2014
Psychotherapy for late-life depression. 2010
The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. 2009
Safety and tolerability of antidepressants: weighing the impact on treatment decisions. 2007
Antidepressant discontinuation syndrome: consensus panel recommendations for clinical management and additional research. 2006
Employing pharmacologic treatment of bipolar disorder to greatest effect. 2004
Depression-free days as a summary measure of the temporal pattern of response and remission in the treatment of major depression: a comparison of venlafaxine, selective serotonin reuptake inhibitors, and placebo. 2003
Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the treatment of major depressive disorder. 2003
New approaches to managing psychotic depression. 2003
Role of executive function in late-life depression. 2003
Weight gain in the treatment of mood disorders. 2003
Clinical use of nefazodone in major depression: a 6-year perspective. 2002
Epidemiology, morbidity, and treatment of overweight and obesity. 2001
Social functioning in depression: a review. 2000
Clinical efficacy of reboxetine in major depression. 2000
New indications for antidepressants. 2000
New strategies for treating chronic depression. 2000
Antidepressant effectiveness in severe depression and melancholia. 1999
Phenomenology and treatment of agitation. 1999
Bipolar disorder: recent issues in diagnosis and classification. 1998
Geriatric dysthymia. 1998
Noradrenergic versus serotonergic antidepressants: predictors of treatment response. 1998
Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome. Discontinuation Consensus Panel. 1997
Psychotherapeutic approaches to the treatment of anxiety and depressive disorders. 1997
Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. Discontinuation Consensus panel. 1997
The treatment of depressed demented patients. 1996
Body dysmorphic disorder: an obsessive-compulsive spectrum disorder, a form of affective spectrum disorder, or both? 1995
Kleptomania, compulsive buying, and binge-eating disorder. 1995
Obsessive compulsive spectrum disorder. 1994
The assessment and treatment of refractory depression. 1994
Serotonin activity in psychotic (delusional) major depression. 1992
Recent developments in the acute somatic treatment of major depression. 1992
Overview of anxiety disorders: prevalence, biology, course, and treatment. 1991
Dosing strategies for antidepressant agents. 1991
Decisions for the clinician in the treatment of panic disorder: when to treat, which treatment to use, and how long to treat. 1991
Anxiety and adjustment disorder: a treatment approach. 1990
Depression and the cancer patient. 1990
Geriatric psychiatry: an update. 1990

VIVO Weill Cornell Medical College

The Journal of clinical psychiatry Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)